U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C31H44O8
Molecular Weight 544.6763
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEPROSCILLARIN

SMILES

CO[C@H]1[C@H](C)O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CCC3=C2)C6=COC(=O)C=C6)[C@H](O)[C@@H]1O

InChI

InChIKey=RKWPZPDLTYBKCL-RVZGXXANSA-N
InChI=1S/C31H44O8/c1-17-27(36-4)25(33)26(34)28(38-17)39-20-9-12-29(2)19(15-20)6-7-23-22(29)10-13-30(3)21(11-14-31(23,30)35)18-5-8-24(32)37-16-18/h5,8,15-17,20-23,25-28,33-35H,6-7,9-14H2,1-4H3/t17-,20-,21+,22-,23+,25-,26+,27-,28-,29-,30+,31-/m0/s1

HIDE SMILES / InChI

Molecular Formula C31H44O8
Molecular Weight 544.6763
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 12 / 12
E/Z Centers 0
Optical Activity UNSPECIFIED

Meproscillarin is a semisynthetic glycoside for the therapy of cardiac insufficiency. Meproscillarin is a drug with a high bioavailability (about 70%). Meproscillarin is at the only non-renal eliminated, lipophilic and short half-life digitalis and is therefore an ideal, cardiac inotropic agent for use in renal insufficiency. Meproscillarin can be used therapeutically in patients with liver cirrhosis, because a toxic accumulation is not to be expected. The rate of side effects of meproscillarin corresponded to that of other cardiac glycosides.

Approval Year

Sample Use Guides

In Vivo Use Guide
2-3 tablets of 0.25 mg daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:36:18 GMT 2025
Edited
by admin
on Mon Mar 31 18:36:18 GMT 2025
Record UNII
WYR1723LO7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MEPROSCILLARIN
INN   MART.   WHO-DD  
INN  
Official Name English
PROSCILLARIDIN-4-METHYL ETHER
MI  
Preferred Name English
3.BETA.-((6-DEOXY-4-O-METHYL-.ALPHA.-L-MANNOPYRANOSYL)OXY)-14-HYDROXYBUFA-4,20,22-TRIENOLIDE
Common Name English
Meproscillarin [WHO-DD]
Common Name English
PROSCILLARIDIN-4-METHYL ETHER [MI]
Common Name English
meproscillarin [INN]
Common Name English
MEPROSCILLARIN [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C78322
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
251-493-6
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
SMS_ID
100000081500
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
PUBCHEM
15942714
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
MERCK INDEX
m9255
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY Merck Index
DRUG CENTRAL
1705
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
NCI_THESAURUS
C87688
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
INN
4012
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID101031613
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
FDA UNII
WYR1723LO7
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
MESH
C009079
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
EVMPD
SUB08758MIG
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
ChEMBL
CHEMBL2106427
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
CAS
33396-37-1
Created by admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY